Nuvalent IncNUVL
± 混在資本関連度
Investigation into fairness of Nuvalent's sale to GSK for $124.00 per share; may seek increased consideration or additional disclosures.
銘柄への影響 5
Biotech & Genomic Medicine
Nuvalent Inc
GSK plcGSK
言及
Digital Finance & Tokenization
Open Lending CorpLPRO
± 混在資本関連度
Investigation into fairness of Open Lending's sale to ANV Group Holdings for $3.15 per share; may seek increased consideration or additional disclosures.
Health Care
Organon & CoOGN
± 混在資本関連度
Investigation into fairness of Organon's sale to Sun Pharmaceutical for $14.00 per share; may seek increased consideration or additional disclosures.
Energy Transition & Power Demand
SUNation Energy Inc.SUNE
± 混在資本関連度
Investigation into fairness of SUNation Energy's merger with Suniva, where SUNation shareholders would own ~1.8% of combined company; may seek increased consideration or additional disclosures.
テーマインパクト
カバレッジ外企業 2
Sun Pharmaceutical Industries Ltd非上場± 混在
関連度
Suniva, Inc.非上場± 混在
関連度